ChiCTR1900022648
尚未开始
/
/
/
2019-04-20
/
/
眼表疾病
Evaluation of the LipiScan Dynamic Meibomian Imager
Evaluation of the LipiScan Dynamic Meibomian Imager
To evaluate the LipiScan for the purposes of capturing, archiving, manipulating and storing digital images of the meibomian glands.
单臂
Ⅳ期
N/A
N/A
美国强生外科视觉有限公司
/
80
/
2019-04-19
2019-06-28
/
1. Minimum 18 years old; 2. Availability, willingness, ability and sufficient cognitive awareness to comply with study protocol, examination procedures and visit; 3. Be willing to provide informed consent and authorization to disclose protected health information or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical procedures.；
登录查看1. Eyelid abnormality that affects eyelid eversion in either eye; 2. Any of the following ocular conditions in either eye within the past 1 month: ocular surgery, trauma, Herpes infection, eye or eyelid recurrent inflammation or infection, active ocular allergy; 3. Subject is pregnant or lactating; 4. Concurrent participation or participation within 30 days prior to study visit in any other ophthalmic clinical trial involving a therapeutic drug or interventional device; 5. Be an employee, associate or relative of an employee of the clinical study site.；
登录查看美国强生外科视觉有限公司
200233
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
